Lisa Meier McShane (Lisa McShane, Lisa M McShane)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 61

Top Topics

Epidermal Growth Factor Receptor

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Molecular cancer therapeutics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 8 (2024)
Julia Krushkal, Yingdong Zhao, Kyle Roney, Weimin Zhu, Alan Brooks, Deborah Wilsker, Ralph E Parchment, Lisa Meier McShane, James H Doroshow
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19 (1) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 8 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 8 (2024)
Julia Krushkal, Yingdong Zhao, Kyle Roney, Weimin Zhu, Alan Brooks, Deborah Wilsker, Ralph E Parchment, Lisa Meier McShane, James H Doroshow
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19 (1) (2024)
Julia Krushkal, Yingdong Zhao, Kyle Roney, Weimin Zhu, Alan Brooks, Deborah Wilsker, Ralph E Parchment, Lisa Meier McShane, James H Doroshow
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19 (1) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, null null, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics 23 (7) (2024)
Julia Krushkal, Yingdong Zhao, Kyle Roney, Weimin Zhu, Alan Brooks, Deborah Wilsker, Ralph E Parchment, Lisa Meier McShane, James H Doroshow
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19 (1) (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 8 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Julia Krushkal, Yingdong Zhao, Kyle Roney, Weimin Zhu, Alan Brooks, Deborah Wilsker, Ralph E Parchment, Lisa Meier McShane, James H Doroshow
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19 (1) (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Dennis A Dean, Anuj Srivastava, Jeffrey W Grover, Min Jin Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A Roth, Bryan E Welm, Ramaswamy Govindan, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis G Carvajal Carmona, Meenhard Herylyn, Michael A Davies, Geoffrey I Shapiro, Ryan C Fields, Jose G Trevino, Joshua C Harrell, James H Doroshow, Jeffrey H Chuang, Jeffrey A Moscow
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Molecular cancer therapeutics (2024)
Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell, James A Zwiebel, Fernanda I Arnaldez, Robert C Gray, Xin Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Mehmet Sitki Copur, Samer S Kasbari, Ravneet Thind, Barbara A Conley, Carlos L Arteaga, Peter J O'Dwyer, Lyndsay N Harris, Helen X Chen, Keith T Flaherty
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lisa Meier McShane, Mark D Rothmann, Thomas R Fleming
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek. Clinical trials (London, England) (2023)
Lisa Meier McShane, Mark D Rothmann, Thomas R Fleming
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek. Clinical trials (London, England) (2023)
Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason John Luke, Hussein A Tawbi, Fangxin Hong, Edith P Mitchell, James A Zwiebel, Helen Chen, Robert C Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Robert J Behrens, Kathryn P Pennington, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Trametinib in Patients With NF1- , GNAQ- , or GNA11 -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 7 (2023)
Peter J O'Dwyer, Robert J Gray, Keith T Flaherty, Helen X Chen, Shuli Li, Victoria Wang, Lisa Meier McShane, David R Patton, James V Tricoli, P Mickey Williams, A John Iafrate, Jeffrey Sklar, Edith P Mitchell, Naoko Takebe, David J Sims, Brent Coffey, Tony Fu, Mark Routbort, Lawrence V Rubinstein, Richard F Little, Carlos L Arteaga, Donna Marinucci, Stanley R Hamilton, Barbara A Conley, Lyndsay N Harris, James H Doroshow
The NCI-MATCH trial: lessons for precision oncology. Nature medicine (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert C Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lyndsay N Harris, Charles David Blanke, Harry P Erba, James M Ford, Robert C Gray, Michael L LeBlanc, Siwen Hu-Lieskovan, Mark R Litzow, Selina M Luger, Funda Meric-Bernstam, Peter J O'Dwyer, Megan K D Othus, Katerina Politi, Lois E Shepherd, Carmen J Allegra, Helen X Chen, Susan Percy Ivy, Larissa A Korde, Richard F Little, Lisa Meier McShane, Jeffrey A Moscow, David R Patton, Magdalena Thurin, Laura M Yee, James H Doroshow
The New NCI Precision Medicine Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert C Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jörg Rahnenführer, Riccardo de Bin, Axel Benner, Federico Ambrogi, Lara Lusa, Anne-Laure Boulesteix, Eugenia Migliavacca, Harald Binder, Stefan Michiels, Willi Sauerbrei, Lisa Meier McShane, null null
Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges. BMC medicine 21 (1) (2023)
Antonio C Wolff, Mark R Somerfield, Mitchell Dowsett, M Elizabeth H Hammond, Daniel F Hayes, Lisa Meier McShane, Thomas J Saphner, Patricia A Spears, Kimberly H Allison
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jörg Rahnenführer, Riccardo de Bin, Axel Benner, Federico Ambrogi, Lara Lusa, Anne-Laure Boulesteix, Eugenia Migliavacca, Harald Binder, Stefan Michiels, Willi Sauerbrei, Lisa Meier McShane, null null
Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges. BMC medicine 21 (1) (2023)
Jörg Rahnenführer, Riccardo de Bin, Axel Benner, Federico Ambrogi, Lara Lusa, Anne-Laure Boulesteix, Eugenia Migliavacca, Harald Binder, Stefan Michiels, Willi Sauerbrei, Lisa Meier McShane, null null
Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges. BMC medicine 21 (1) (2023)
Lisa Meier McShane, Mark D Rothmann, Thomas R Fleming
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek. Clinical trials (London, England) (2023)
Daniel F Hayes, Roy S Herbst, Jonathan L Myles, Suzanne L Topalian, Sophia L Yohe, Naomi Aronson, Andrew M Bellizzi, Upal Basu Roy, Georganne Bradshaw, Robin H Edwards, Ehab A El-Gabry, Julia A Elvin, Thomas F Gajewski, Lisa Meier McShane, Matthew Oberley, Reena Philip, David L Rimm, Jason N Rosenbaum, Eric H Rubin, Lisa Schlager, Shimere W Sherwood, Mark D Stewart, Janis M Taube, Magdalena Thurin, Patricia Vasalos, Jordan Laser
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit. JCO precision oncology 6 (2022)
Norah L Henry, Mark R Somerfield, Zoneddy Dayao, Anthony D Elias, Kevin Kalinsky, Lisa Meier McShane, Beverly Moy, Ben Ho Park, Kelly M Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica M Stringer-Reasor, Melinda Telli, Nicholas C Turner, Angela M DeMichele
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Kevin K Dobbin, Lisa Meier McShane
Sample size methods for evaluation of predictive biomarkers. Statistics in medicine 41 (16) (2022)
Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy Shih-Hsin Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B. JCO precision oncology 6 (2022)
Torsten O Nielsen, Samuel C Y Leung, Lisa Meier McShane, Mitch Dowsett, Daniel F Hayes, null null
Response to Zhang and Yang. Journal of the National Cancer Institute 113 (11) (2022)
Erich P Huang, James P B O'Connor, Lisa Meier McShane, Maryellen L Giger, Philippe Lambin, Paul E Kinahan, Eliot L Siegel, Lalitha K Shankar
Criteria for the translation of radiomics into clinically useful tests. Nature reviews. Clinical oncology (2022)
Daniel Louis Hertz, Lisa Meier McShane, Daniel F Hayes
Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)
Torsten O Nielsen, Samuel C Y Leung, David L Rimm, Andrew Dodson, Balazs Acs, Sunil S Badve, Carsten Denkert, Matthew J Ellis, Susan Fineberg, Margaret Flowers, Hans Heinrich Kreipe, Anne-Vibeke Laenkholm, Hongchao Pan, Frédérique M Penault-Llorca, Mei-Yin C Polley, Roberto Salgado, Ian E Smith, Tomoharu Sugie, Timothy J Whelan, Lisa Meier McShane, Mitchell Dowsett, Daniel F Hayes
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group. Journal of the National Cancer Institute 113 (7) (2022)
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, Edith P Mitchell, John J Wright, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jennifer M Suga, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Ian E Krop, Opeyemi A Jagede, Juneko E Grilley Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Scott A Kono, James M Ford, Agustin A Garcia, Xingwei D Sui, Robert D Siegel, Brian M Slomovitz, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Taselisib in PIK3CA -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 6 (2022)
Suzanne B Hendrix, Robin Mogg, Sue-Jane Wang, Aloka G Chakravarty, Klaus Romero, Samuel P Dickson, John-Michael Sauer, Lisa Meier McShane
Perspectives on statistical strategies for the regulatory biomarker qualification process. Biomarkers in medicine 15 (9) (2021)
James M Cleary, Victoria Wang, Rebecca S Heist, E Scott Kopetz, Edith P Mitchell, James A Zwiebel, Kevin S Kapner, Helen X Chen, Shuli Li, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, Funda Meric-Bernstam, Melissa S Dillmon, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Andrew J Aguirre, Peter J O'Dwyer, Lyndsay N Harris, Carlos L Arteaga, Helen X Chen, Keith T Flaherty
Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Douglas B Johnson, Fengmin Zhao, Marcus Noel, Gregory J Riely, Edith P Mitchell, John J Wright, Helen X Chen, Robert C Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David Patton, P Mickey Williams, Stanly R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Keith T Flaherty
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2020)
Julia Krushkal, Simarjeet Negi, Laura M Yee, Jason R Evans, Tanja Grkovic, Alida Palmisano, Jianwen Fang, Hari Sankaran, Lisa Meier McShane, Yingdong Zhao, Barry R Oâ Keefe
Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural products. Molecular oncology 15 (2) (2020)
Keith T Flaherty, Robert J Gray, Helen X Chen, Shuli Li, Lisa Meier McShane, David R Patton, Stanley R Hamilton, P Mickey Williams, A John Iafrate, Jeffrey Sklar, Edith P Mitchell, Lyndsay N Harris, Naoko Takebe, David J Sims, Brent Coffey, Tony Fu, Mark J Routbort, James A Zwiebel, Lawrence V Rubinstein, Richard F Little, Carlos L Arteaga, Robert Comis, Jeffrey S Abrams, Peter J O'Dwyer, Barbara A Conley, null null
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
David L Rimm, Samuel C Y Leung, Lisa Meier McShane, Yalai Bai, Anita L Bane, John M S Bartlett, Jane Bayani, Martin C Chang, Michelle Dean, Carsten Denkert, Emeka K Enwere, Chad Galderisi, Abhi Gholap, Judith C Hugh, Anagha Jadhav, Elizabeth N Kornaga, Arvydas Laurinavicius, Richard Levenson, Joema Lima, Keith Miller, Liron Pantanowitz, Tammy Piper, Jason Ruan, Malini Srinivasan, Shakeel Virk, Ying Wu, Hua Yang, Daniel F Hayes, Torsten O Nielsen, Mitch Dowsett
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (1) (2018)
Richard F Little, Lisa Meier McShane
Measure for measure: minimal residual disease in CLL. Blood 128 (24) (2018)
Mei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, Mauro G Mastropasqua, Lila A Zabaglo, John M S Bartlett, Lisa Meier McShane, Rebecca A Enos, Sunil S Badve, Anita L Bane, Signe Borgquist, Susan Fineberg, Ming-Gang Lin, Allen M Gown, Dorthe Grabau, Carolina Gutierrez, Judith C Hugh, Takuya Moriya, Yasuyo Ohi, C Kent Osborne, Frédérique M Penault-Llorca, Tammy Piper, Peggy L Porter, Takashi Sakatani, Roberto Salgado, Jane Starczynski, Anne-Vibeke Lænkholm, Giuseppe Viale, Mitch Dowsett, Daniel F Hayes, Torsten O Nielsen
An international study to increase concordance in Ki67 scoring. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 28 (6) (2015)